- Home
- DYN vs MCRI Comparison
DYN vs MCRI Comparison
Compare DYN & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- MCRI
- Stock Information
- Founded
- DYN 1984
- MCRI 1972
- Country
- DYN United States
- MCRI United States
- Employees
- DYN N/A
- MCRI N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- MCRI Hotels/Resorts
- Sector
- DYN Health Care
- MCRI Consumer Discretionary
- Exchange
- DYN Nasdaq
- MCRI Nasdaq
- Market Cap
- DYN 1.9B
- MCRI 1.9B
- IPO Year
- DYN 2020
- MCRI 1993
- Fundamental
- Price
- DYN $13.15
- MCRI $101.40
- Analyst Decision
- DYN Strong Buy
- MCRI Hold
- Analyst Count
- DYN 14
- MCRI 5
- Target Price
- DYN $34.93
- MCRI $96.20
- AVG Volume (30 Days)
- DYN 2.2M
- MCRI 88.0K
- Earning Date
- DYN 11-11-2025
- MCRI 10-22-2025
- Dividend Yield
- DYN N/A
- MCRI 1.17%
- EPS Growth
- DYN N/A
- MCRI N/A
- EPS
- DYN N/A
- MCRI 4.22
- Revenue
- DYN N/A
- MCRI $534,693,999.00
- Revenue This Year
- DYN N/A
- MCRI $6.87
- Revenue Next Year
- DYN N/A
- MCRI $4.19
- P/E Ratio
- DYN N/A
- MCRI $24.29
- Revenue Growth
- DYN N/A
- MCRI 4.65
- 52 Week Low
- DYN $6.36
- MCRI $69.99
- 52 Week High
- DYN $37.08
- MCRI $113.88
- Technical
- Relative Strength Index (RSI)
- DYN 56.80
- MCRI 48.09
- Support Level
- DYN $12.65
- MCRI $100.20
- Resistance Level
- DYN $13.68
- MCRI $104.53
- Average True Range (ATR)
- DYN 0.67
- MCRI 2.36
- MACD
- DYN -0.16
- MCRI -0.46
- Stochastic Oscillator
- DYN 30.72
- MCRI 18.32
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.